This patent covers the stem cell that gives rise to T cells. The claims actually comprise methods of isolation of a precursor that is CD34+, Leu8+ and CD7+. This patent is useful not only for purifying T cell stem cells for ex vivo growth and expansion, but also for identifying the T cell precursor pool in patients with various diseases.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.